Savitz Adam

CHIEF MEDICAL OFFICERAlto Neuroscience, Inc. (ANRO) · full profile →Form 4 · filed Feb 7, 2024
Net Buying
Open-Market Buys
$272K
Open-Market Sells
$0
Net Open-Market Flow
$272K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 6, 2024Buy(P)17K$16.00$272K25K
Feb 6, 2024Conversion(C)8K8K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 6, 2024Conversion(C)17K$00

Transaction Codes

P
Open-market purchase
C
Conversion of a derivative

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-24-002936) within minutes of acceptance. Every field above traces to the original document. Verify it directly: